Among heroin use disorder patients on opioid agonist treatment, high stress sensitivity was associated with more severe psychopathology, worse well-being, and greater social impairment — particularly in women with low income.
Read this if you work in addiction treatment or want to understand how stress sensitivity affects recovery from opioid use disorder.
Stress > substance useInability to cope with daily life, not drug use, may define long-term heroin disorder outcomes
What the researchers found
Researchers found that stress sensitivity (measured by the H/PTSD-Spectrum questionnaire) was positively correlated with altered mental status, legal problems, treatment load, and all psychopathology indexes. Patients with high stress sensitivity were more often female with low income, showed more severe mental status at treatment entry, greater difficulty with work adaptation, and more risky behaviors during treatment. Cannabis craving was assessed but stress sensitivity's core impact was on social and behavioral functioning rather than specific substance use patterns.
Why it matters
This study reframes heroin use disorder outcomes. Rather than measuring success by whether someone stops using drugs, the real long-term challenge may be an acquired inability to cope with everyday life stressors. This has implications for how treatment programs are designed and evaluated.
The numbers in context
- Stress sensitivity negatively correlated with the "best week in last five years" well-being index
- Patients with high stress sensitivity had more severe mental status at treatment entry
- High-stress sensitivity group was predominantly female with low income
- Multiple validated instruments used: H/PTSD-S, SCL-90, CRAV-HERO, D-SWS, CPSI, MC-Q
How the study worked
Cross-sectional study of heroin use disorder patients undergoing opioid agonist treatment. Used multiple validated questionnaires to assess stress sensitivity, psychopathology, well-being, cocaine problems, and cannabis craving. Compared patients with and without problematic stress sensitivity levels.
Who was studied
Heroin use disorder patients undergoing opioid agonist treatment
What this study cannot tell us
Cross-sectional design cannot establish causation between stress sensitivity and outcomes. Cannabis-related measures (MC-Q) were included but the study focused primarily on heroin treatment outcomes. The study population was already in treatment, which may not represent all people with heroin use disorder.
How to read the evidence
Cross-sectional observational study with validated instruments. Identifies associations but cannot establish causation.
When this study was published
Published in 2023. Reflects current thinking on stress-related outcomes in addiction medicine.
The bigger picture
Addiction research increasingly recognizes that substance use is often a symptom of deeper issues with stress regulation and emotional processing. This study adds evidence that the inability to cope with normal life events — not drug-taking itself — may be the core feature of addiction's long-term impact.
Questions still open
- Could targeted stress-reduction interventions improve outcomes for high-stress-sensitivity patients in opioid treatment?
- Does cannabis use serve a self-medication role for stress in this population?
- Would early screening for stress sensitivity at treatment entry allow for better-tailored interventions?
Read the original research
Characteristics of Stress Sensitivity in Heroin Use Disorder Patients during Their Opioid Agonist Treatment.
International journal of environmental research and public health, 20(5)
Citation
Della Rocca, Filippo; Maremmani, Angelo G I; Bacciardi, Silvia; Pacini, Matteo; Lamanna, Francesco; Tripodi, Beniamino; Miccoli, Mario; Maremmani, Icro. (2023). Characteristics of Stress Sensitivity in Heroin Use Disorder Patients during Their Opioid Agonist Treatment.. International journal of environmental research and public health, 20(5). https://doi.org/10.3390/ijerph20054566